Embla Medical hf (OCSE:EMBLA)
kr 34.9 -0.7 (-1.97%) Market Cap: 14.90 Bil Enterprise Value: 18.15 Bil PE Ratio: 31.53 PB Ratio: 2.82 GF Score: 71/100

Q3 2021 Ossur hf Earnings Call Transcript

Oct 26, 2021 / 07:00AM GMT
Release Date Price: kr43.2
Operator

Ladies and gentlemen, welcome to the Ãssur Q3 results 2021. Today, I am pleased to present Mr. Jon Sigurdsson, President and CEO; and Mr. Sveinn Solvason, CFO. (Operator Instructions)

Mr. Sigurdsson and Mr. Solvason, please begin.

Jon Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. Thank you

(technical difficulty)

Ãssur investor conference call, where we will cover the result for third quarter of 2021. My name is Jon Sigurdsson, and I'm the President and CEO. And with me here today is Sveinn Solvason, our CFO. We will begin by going through the highlights of the quarter and ending with our guidance for 2021. A question-and-answer session will then follow.

Sales in the third quarter of 2021 amounted to $180 million, which corresponds to 4% organic growth. Sales in EMEA and APAC were strong with the exception of Australia which was impacted by lockdown measures. In addition, we experienced softer sales in Americas due to effect from COVID-19 Delta variant in the quarter. Sales

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot